Paul Tudor Jones II acquired 39.5 Thousand Biogen shares worth $4.67 Million. That's 0.06% of their equity portfolio (419th largest holding). The first Biogen trade was made in Q2 2013. Since then Paul Tudor Jones II bought shares 31 more times and sold shares on 23 occasions. The investor's estimated purchase price is $6.77 Million, resulting in a loss of 31%.
NEW YORK, NY / ACCESSWIRE / July 22, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery ...
LOS ANGELES, CA / ACCESSWIRE / July 22, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsu...
NEW YORK, July 22, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB).
NEW YORK, NY / ACCESSWIRE / July 22, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery ...